Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this

Aurélie Caye1,2, Kevin Rouault-Pierre3,4, Marion Strullu1,2

  • 1INSERM UMR_S1131, Institut de Recherche Saint-Louis, Université de Paris, Paris, France.

Leukemia
|November 29, 2019
PubMed

Insights

This study identifies the specific Juvenile myelomonocytic leukemia-propagating cells (JMML-PCs) responsible for disease initiation and progression. These cells maintain disease features across diagnosis and relapse, offering new therapeutic targets.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Juvenile myelomonocytic leukemia (JMML) is a rare, aggressive childhood cancer driven by RAS mutations.
  • The identity of JMML-propagating cells (JMML-PCs) and the disease's clonal structure have remained unclear.

Purpose of the Study:

  • To identify JMML-PCs and elucidate the clonal architecture of JMML.
  • To understand the cellular origins and heterogeneity of JMML.

Main Methods:

  • Genomic analyses including exome sequencing and RNA-seq.
  • Colony-forming assays and xenograft studies.
  • Integrated analysis of multi-omics data.

Main Results:

  • JMML-PCs were identified and shown to faithfully reproduce JMML characteristics.
  • Complex clonal organization (dominant/minor clones) was observed at diagnosis and relapse.
  • JMML-PCs are not exclusively confined to hematopoietic stem cells, indicating disease heterogeneity.

Conclusions:

  • This research clarifies the ontogeny of JMML and the identity of JMML-PCs.
  • The findings provide models for disease monitoring and therapeutic development.
  • Understanding JMML-PC heterogeneity is crucial for effective treatment strategies.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.7K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
4.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.8K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K